Objective: To assess the potential role of conventional sonography and colour¯ow Doppler (CFD) sonography (CFDS) in the differential diagnosis of toxic multinodular goitres. Subjects and methods: We investigated 55 patients with untreated hyperthyroidism (24 with typical toxic diffuse goitre of Graves' disease (Group A); 26 with multinodular goitre (Group B); and ®ve with single toxic adenoma (Group C); 22 euthyroid subjects (12 with non-toxic multinodular goitre (Group D) and ten normal subjects (Group E)) were included as controls. In all cases free thyroxine, free tri-iodothyronine, TSH, TSH receptor antibodies (TRAb), anti-thyroperoxidase antibody, anti-thyroglobulin antibodies and anti-thyroid microsomal antibodies were determined and a [ 99m Tc]pertechnetate thyroid scan was performed.
Introduction
The pathogenesis of toxic multinodular goitre, also called Marine±Lenhart syndrome (1, 2) has been debated in the past. In particular, the question has been raised as to whether, similar to the situation in toxic diffuse goitre of Graves' disease, thyroid autoimmunity and thyroid-stimulating antibody (TSAb) may play a role in the pathogenesis of this disorder (3±11). An important contribution to this topic was provided by Kraiem et al. (8) who clearly identi®ed a subgroup of hyperthyroid patients with a multinodular variant of Graves' disease distinct from those with multiple autonomously functioning nodules. Although in some cases the differential diagnosis between autoimmune and non-autoimmune variants of toxic multinodular goitre may be made on clinical grounds (e.g. the coexistence of toxic multinodular goitre and thyroid ophthalmopathy is diagnostic of Graves' disease), in several cases the two conditions may be dif®cult to discriminate. Apart from the detection of serum TSAb and other anti-thyroid autoantibodies, an important contribution to the differential diagnosis may derive from the scintiscan (12) . Patients with toxic multinodular goitres may display either diffuse but uneven distribution of the radioisotope, or multiple discrete`hot' nodules surrounded by`cold' suppressed thyroid tissue. The diffuse pattern is generally observed in the autoimmune variant of toxic multinodular goitre, while the other pattern is more frequent in patients with the non-autoimmune variant, but the scintiscan does not provide a complete discrimination (8) .
Conventional sonography and colour¯ow Doppler (CFD) sonography (CFDS) have been widely used in past years for the morphological and functional characterization of different kinds of hyperthyroid conditions (13) . In untreated Graves' disease, the conventional sonographic pattern is typically hypoechogenic and CFDS displays a marked increase in intrathyroidal blood ow (so called`thyroid inferno') (14, 15) . This pattern is strictly related to the activity of Graves' disease (16±19) and it is believed to result from TSAb stimulation (15) . Unlike with toxic diffuse goitre, very few sonographic studies have been carried out in toxic multinodular goitre. It has been recently reported that CFDS may identify functionally autonomous thyroid`hot' nodules by their increased intranodular vascularity in both overt and subclinical hyperthyroidism (20) . To the best of our knowledge, until now no study has speci®cally addressed the potential role of conventional sonography and CFDS in the differential diagnosis of the autoimmune and nonautoimmune variants of toxic multinodular goitre.
In the present paper we provide evidence that CFDS is a very sensitive and speci®c tool for a`®rst-line' differential diagnosis between autoimmune and nonautoimmune multinodular goitres.
Subjects and procedures

Patients
A total of 55 untreated consecutive hyperthyroid patients were studied. These included 24 patients with typical toxic diffuse goitre of Graves' disease (Group A) and 26 patients with multinodular goitre (Group B). This was a heterogeneous group including four patients with clinically evident Graves' ophthalmopathy, i.e. with an obvious multinodular variant of Graves' disease. However, for the purpose of this investigation, all patients were blindly sub-classi®ed only on the basis of CFDS pattern into B-1 and B-2 Groups (see Tables 1 and  2 and Results for details) by two of us (F B and M L) who were unaware of the presence/absence of eye signs, as well as of scintiscan and thyroid autoantibody assays. All patients of A and B-1 Groups had overt hyperthyroidism with undetectable (< 0.01 mU/l) serum thyrotrophin (TSH) and increased serum free tri-iodothyronine (FT3) (> 8.6 pmol/l) and free thyroxine (FT4) (> 20.4 pmol/l). Four out of eight patients of Group B-2 had subclinical hyperthyroidism (undetectable TSH with FT4 and FT3 still within the normal range). As controls, ®ve patients with single toxic (three) and pre-toxic (two) adenoma (Group C), 12 euthyroid patients with non-toxic multinodular goitre (Group D) and ten normal euthyroid subjects (Group E) were included. The main clinical and biochemical features of the patients and controls are reported in Table 1 .
Conventional sonography and CFDS
Conventional sonography and CFDS were performed using an Acuson 128 XP 10 colour Doppler system (Acuson Co., Mountain View, CA, USA) with a 7.5 MHz linear electronic transducer. In all cases the examination included ®rst a conventional grey-scale sonography, followed by CFDS. Thyroid volume was calculated by the ellipsoid method (width´length´thickness´p/6) as described elsewhere (21); all thyroid nodules were identi®ed, localized, counted and their diameters measured. CFDS images were obtained by transverse and longitudinal plane scanning and colour gain was adjusted to avoid artefacts with the probe repetition frequency at 750 Hz. The blood¯ow was visualized by red and blue spots indicating the direction of¯ow toward (red) and away (blue) from the transducer. Quantitative¯ow evaluation was carried out by measuring (mean of four or ®ve samplings at the parenchymal and nodular level) the maximal peak systolic velocity (PSV) of intrathyroid arteries. The CFDS patterns were classi®ed as previously reported (22) . Pattern 0: absent intraparenchymal (or nodular) vascularity or minimal spots; pattern I: patchy uneven intraparenchymal colour Doppler signal distribution (only peripheral in the case of nodules); pattern II: mild increase in CFD signal with patchy distribution (for nodules: mainly peripheral); pattern III: markedly increased CFD signal with diffuse homogeneous distribution, including the`thyroid inferno' (14) (for nodules: intranodular and peripheral vascularity).
Assays
All hormone and antibody assays were carried out using commercial kits. 
Thyroid scintiscan
Thyroid scintigraphy was performed by means of a computerized gamma camera equipped with a pinhole collimator (Elscint, SP4; Haifa, Israel) 30 min after i.v. injection of 110 MBq [ 99m Tc]pertechnetate. The scan was performed in anterior, left-anterior oblique and rightanterior oblique projections. The scintigraphic patterns were categorized into pattern A (uneven, patchy radionuclide distribution) and pattern B (localized uptake in multiple discrete nodules) (8) , by two of us (M P, A S) who were unaware of the sonographic results.
Statistical analysis
Quantitative data are expressed as means 6 S.D. and comparison between means was evaluated using Student's t-test.
Results
Conventional sonography and CFDS results
The results obtained with conventional sonography and CFDS in the study groups are summarized in Table 2 CFDS pattern in hyperthyroid patients: relation to TRAb and thyroid autoimmunity
As shown in Table 1 , a similar proportion of thyroid ophthalmopathy, TRAb and other thyroid autoantibody prevalence was found in patients from Group A and B-1, while no evidence of thyroid ophthalmopathy and negative TRAb, anti-Tg, anti-M and anti-TPO were consistently found in all patients of Group B-2 and C. The comparison of individual clinical and immunological data of patients with toxic multinodular goitre from Groups B-1 and B-2 is detailed in Table 3 .
Thyroid scintiscan pattern in toxic multinodular goitres: relation to TRAb and thyroid autoimmunity
Group B patients with toxic multinodular goitre were then subdivided according to their scintigraphic patterns. The comparison of the individual clinical and immunological features of the two scintigraphic subgroups is detailed in Table 4 . As expected, the prevalence of thyroid autoimmunity markers was higher in patients with scintiscan pattern A (diffuse uneven radionuclide distribution), but one hyperthyroid patient with positive serum thyroid autoantibodies and one with clear active Graves' ophthalmopathy showed a scintigraphic pattern of localized uptake.
Comparison of CFDS and scintiscan in toxic multinodular goitre
The prevalence of scintigraphic patterns in patients from CFDS-de®ned Groups B-1 and B-2 is reported in Fig. 2 . The large majority (16 out of 18 89%) of patients with increased extranodular vascularity (B-1) displayed diffuse uneven uptake (pattern scan A), while localized uptake (pattern scan B) was observed in the remaining two patients. In patients with increased nodular vascularity (B-2), seven out of eight (87.5%) displayed localized uptake, while in the remaining case a diffuse uneven uptake was observed.
Discussion
The CFDS patterns observed in untreated hyperthyroid patients with Graves' disease and diffuse goitre were in keeping with several previous studies showing that an hypoecogenic thyroid parenchyma with markedly increased blood¯ow (CFDS pattern III) is a hallmark of this disease (13, 14, 16±19) . The results obtained in hyperthyroid patients with single toxic adenoma displayed a pattern of increased nodular vascularization (CFDS pattern III) on a background of a perinodular parenchyma with normal vascular¯ow. Again, this ®nding is in keeping with previous studies showing that increased vascularization is consistently found in autonomous`hot' thyroid nodules (13, 20) , being observed even in pre-toxic conditions, before the complete suppression of serum TSH concentrations (20) . When CFDS patterns observed in hyperthyroid patients with multinodular goitres were analysed, two clearly different combinations were observed. The ®rst was characterized by nodules with normal vascularization (CFDS patterns 0-I) surrounded by hypoechogenic thyroid tissue with markedly increased blood¯ow showing the same characteristics of diffuse toxic goitre; the second by two or more heterogeneous nodules with increased blood¯ow (CFDS pattern III), often accompanied by mixed/solid normovascular nodules, within a normoechogenic normovascular parenchyma. The majority of patients with toxic multinodular goitre with hypoechogenic, hypervascularized extranodular parenchyma displayed evidence of associated autoimmunity such as positive serum TRAb and other thyroid autoantibodies and/or unequivocal Graves' ophthalmopathy. In contrast, none of the hyperthyroid patients with toxic multinodular goitre showing increased nodular vascularity had positive serum TRAb and/or other thyroid autoantibodies, or presented clinical evidence of Graves' ophthalmopathy. These results strongly support the concept that the CFDS pattern allows discrimination between an`autoimmune' form of toxic multinodular goitre (actually Graves' disease developed within a non-toxic multinodular goitre) corresponding to our study Group B-1, from a non-autoimmune form due to multiple autonomous nodules.
In contrast to iodine-suf®cient countries, where classical Graves' disease with diffuse goitre represents the most common cause of hyperthyroidism, toxic multinodular goitres are particularly frequent in iodine-de®cient populations (23, 24) . This may be due to progressive development of autonomous thyroid tissue (25±29) or to superimposed autoimmune (TSAb) stimulation (11, 30) . To differentiate the two forms of toxic multinodular goitre, Kraiem et al. (8) employed the same clinical and serological criteria used by us, while the morphological and functional thyroid evaluation was performed by scintiscan. In their hands, the autoimmune variant of toxic multinodular goitre was frequently associated with a scintigraphic pattern (called pattern A) of diffuse, but uneven (patchy) radionuclide distribution, while the typical scintigraphic pattern of the non-immunogenic variant was represented by multiple discrete`hot' nodules of varying size and activity (pattern B). The morphological discrimination, however, was not complete, with some patients showing one or more markers of thyroid autoimmunity included in pattern B and vice versa.
In the present investigation we obtained very similar results when patients with toxic multinodular goitre were analysed according to their thyroid scans. The comparison of thyroid CFDS and thyroid scintigraphy in the same patients showed that, as expected, the scintigraphic pattern A corresponded in most cases to Tc scintigraphy. We are aware, however, that it is dif®cult from our present results to fully compare the sensitivity and speci®city of thyroid CFDS with thyroid scintigraphy in the diagnostic evaluation of toxic multinodular goitre. For example, it is conceivable that the use of radioiodine could have provided slightly different results, because this radionuclide is a more`physiological' thyroid substrate than 99m Tc and discrepant radioiodine/ 99m Tc scans have been occasionally reported in thyroid nodular diseases (31, 32) . Nevertheless, our data provide further evidence that the CFDS technique is a very sensitive and speci®c method to precisely identify hyperfunctioning thyroid tissue. Moreover, our ®nding of increased blood¯ow strictly limited to the hyperfunctioning thyroid tissue (extranodular parenchyma or nodules) provides further evidence for the concept that increased vascularization is due to primary thyroid tissue hyperfunction and is not affected by the increased circulating thyroid hormone concentration per se (22 vascularity in thyroid nodules (e.g. high proliferative potential such as malignant tumours (33) coincidentally present in toxic goitres (34, 35) ) might confound the CFDS pattern in individual patients.
In conclusion, this study shows that combined conventional sonography and CFDS may easily distinguish in most cases nodular variants of Graves' disease from non-immunogenic forms of toxic multinodular goitre and con®rms the clinical usefulness of this technique in the ®rst-line evaluation of hyperthyroid patients.
